Drug Database
Back to search

Belgium· BE-AMP-SAM134373-00

Atronase 0.3 mg/ml

A ipratropium bromide product containing ipratropium bromide monohydrate, registered in Belgium by Sanofi Belgium. The same ATC class is registered in 7 of our 19 countries.

ATC R01AX03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAtronase 0.3 mg/mlATCR01AX03REGISTER NO.BE-AMP-SAM134373-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ipratropium bromide monohydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ipratropium bromide is registered in 7 of 19 countries.

Countries holding a registration under ATC R01AX03 (ipratropium bromide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search ipratropium bromide products by name

Ipratropium bromide · ATC R01AX03

7 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ipratropium Bromide Monohydrate
Manufacturer
Sanofi Belgium
Country
Belgium (BE)
ATC code
R01AX03
ATC class
Ipratropium bromide
Defined daily dose
0.24 mg, N
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1239607

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

93 interactions on record for ipratropium bromide.

Graded by severity as the source publishes them — 93 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ipratropium bromide against other medicinesHow interaction checks work

Ipratropium bromide · interactions on record

93 records

  • 93 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Ipratropium bromide in 16 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All ipratropium bromide products

    Authorised across Europe · EMA

    The same active substance is authorised in 26 EEA countries. Names it is sold under:

    • Austria · Atrovent - Dosieraerosol, Ipratropiumbromid Infectopharm
    • Cyprus · Atrovent
    • Czechia · Atrovent, Atrovent N
    • Germany · Atrovent, Atrovent Ls
    • Denmark · Atrovent, Ipratropiumbromid Teva
    • Estonia · Atrovent N
    • Spain · Atroaldo, Atrovent
    • Finland · Atrovent, Atrovent Eco
    • France · Atrovent, Atrovent Adultes
    • United Kingdom (Northern Ireland) · Atrovent Inhaler Cfc-Free, Atrovent Udvs
    • Greece · Atrovent, Broncovent
    • Croatia · Atrovent, Atrovent N
    • Hungary · Atrovent N
    • Ireland · Atrovent 250 Udvs, Atrovent 500 Udvs
    • Iceland · Atrovent, Lomuspray
    • Italy · Atem, Nasipral
    • Lithuania · Atrovent N
    • Luxembourg · Atrovent, Atrovent Hfa
    • Malta · Atroaldo, Atrovent Inhaler Cfc-Free
    • Netherlands · Atrovent, Atrovent Unit Dose
    • Norway · Atrovent, Ipraxa
    • Poland · Atrodil, Atrovent
    • Portugal · Atrovent, Atrovent Pa
    • Romania · Ipravent Inhaler
    • Sweden · Atrovent, Ipravent
    • Slovakia · Atrovent N

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/be9b2f23-ed43-49e0-b838-1bf0eddeeb82
GET /v1/drugs/be9b2f23-ed43-49e0-b838-1bf0eddeeb82?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Nasal spray, solution",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Atronase 0.3 mg/ml",
  "name_fr": "Atronase 0.3 mg/ml",
  "name_nl": "Atronase 0.3 mg/ml",
  "amp_code": "SAM134373-00",
  "strengths": [
    "21.0000",
    "21.0000",
    "20.0000",
    "20.0000",
    "0.2500",
    "0.5000",
    "8.8000"
  ],
  "pack_count": 1,
  "substances": [
    "Ipratropium Bromide Monohydrate",
    "Ipratropium Bromide Anhydrous",
    "Benzalkonium Chloride",
    "Disodium Edetate",
    "Sodium Chloride",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ipratropium Bromide",
  "authorisation_numbers": [
    "BE134373"
  ]
}
    API referenceMCP serverPlans

    See everything about ipratropium bromide.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console